Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock

RESUMO

Animal studies with hypertonic solutins suggest that they can achieve resuscitation of hypovolemic shock with extremely small volumes. Such small volume ressuscitation might be ideal in the field treatment of injured patients. Our studies to date, with 60 patients enterd into a prospective, randomized, placebo-controlled, and double-blind clinical trial, suggest that the use of a 7.5% NaCl/Dextran 70 solution increases blood pressures during transport. The solutions have been safe, and we have encoutered no adverse side effects from their use. Survival rates to date favor use of the solutions, but we do not have convincing statistical significance yet in that regard